alza 18 Pill - yellow capsule/oblong

Pill with imprint alza 18 is Yellow, Capsule/Oblong and has been identified as Methylphenidate Hydrochloride Extended-Release 18 mg. It is supplied by Watson Pharmaceuticals.

Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 18 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for alza 18

Methylphenidate Hydrochloride Extended-Release

Imprint: alza 18
Strength: 18 mg
Color: Yellow
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: CNS stimulants
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: 2 - High potential for abuse
Labeler / Supplier: Watson Pharmaceuticals
Inactive Ingredients: butylated hydroxytoluene, carnauba wax, cellulose acetate, phosphoric acid, sodium chloride, propylene glycol, stearic acid, succinic acid, ferrosoferric oxide, titanium dioxide, triacetin
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00591-2715 (Discontinued)	Watson Pharmaceuticals, Inc.
50458-0585	Ortho-McNeil Pharmaceutical, LLC
68084-0890 (Discontinued)	Amerisource Health Services
54868-4489 (Discontinued)	Physicians Total Care Inc. (repackager)
55289-0835	PDRX Pharmaceuticals Inc. (repackager)